Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / CL A
-
Number of holders
-
177
-
Total 13F shares, excl. options
-
26,688,004
-
Shares change
-
+108,675
-
Total reported value, excl. options
-
$2,685,200,348
-
Value change
-
-$18,352,591
-
Put/Call ratio
-
249%
-
Number of buys
-
85
-
Number of sells
-
-84
-
Price
-
$100.61
Significant Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q3 2021
228 filings reported holding RETA - REATA PHARMACEUTICALS INC - CL A as of Q3 2021.
REATA PHARMACEUTICALS INC - CL A (RETA) has 177 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26,688,004 shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4,243,272 shares), Invesco Ltd. (3,438,804 shares), CPMG Inc (2,896,901 shares), VANGUARD GROUP INC (2,540,490 shares), BlackRock Inc. (2,120,722 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,056,787 shares), FRANKLIN RESOURCES INC (1,024,298 shares), FMR LLC (817,658 shares), Duquesne Family Office LLC (695,033 shares), and Camber Capital Management LP (685,000 shares).
This table shows the top 177 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.